Dialogue Health Technologies (TSE:CARE – Get Rating) was downgraded by research analysts at CIBC from an “outperform” rating to a “neutral” rating in a note issued to investors on Tuesday, BayStreet.CA reports. They presently have a C$4.00 price objective on the stock, down from their previous price objective of C$7.00. CIBC’s target price would suggest […]
Dialogue Health Technologies (TSE: CARE) has recently received a number of price target changes and ratings updates: 5/13/2022 – Dialogue Health Technologies had its price target lowered by analysts at Royal Bank of Canada from C$10.00 to C$7.00. They now have a “sector perform” rating on the stock. 5/12/2022 – Dialogue Health Technologies had its […]
Dialogue Health Technologies (TSE:CARE – Get Rating) had its price target reduced by investment analysts at Royal Bank of Canada from C$10.00 to C$7.00 in a research note issued to investors on Friday, BayStreet.CA reports. The firm presently has a “sector perform” rating on the stock. Royal Bank of Canada’s price objective would suggest a […]
Dialogue Health Technologies (TSE:CARE – Get Rating) had its price objective cut by Scotiabank from C$11.00 to C$8.50 in a research note issued on Thursday, BayStreet.CA reports. Scotiabank’s price objective would suggest a potential upside of 109.88% from the company’s previous close. Separately, TD Securities lowered Dialogue Health Technologies from a “buy” rating to a […]
Dialogue Health Technologies (TSE:CARE – Get Rating) had its target price dropped by equities research analysts at CIBC from C$9.50 to C$7.00 in a note issued to investors on Thursday, BayStreet.CA reports. The firm presently has an “outperform” rating on the stock. CIBC’s price target would suggest a potential upside of 72.84% from the stock’s […]